Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares (NQ:KNSA)

28.41 +0.11 (+0.39%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 674,257
Open 28.06
Bid (Size) 25.10 (1)
Ask (Size) 29.40 (5)
Prev. Close 28.30
Today's Range 27.65 - 28.68
52wk Range 17.38 - 30.69
Shares Outstanding 71,726,685
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Pony AI, Hims & Hers And Frontdoor Are Among Top 11 Mid-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio?
Top performers last week: PONY, HIMS, ODD, MTSR, CGON, KNSA, KC, FTDR, ATI, PRDO, and IRTC. Have you invested in them? 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence

Performance

YTD
+42.5%
+42.5%
1 Month
+8.2%
+8.2%
3 Month
+23.7%
+23.7%
6 Month
+39.8%
+39.8%
1 Year
+53.3%
+53.3%

More News

Read More
Kiniksa Pharmaceuticals Announces GRAMMY® Award-Winning Country Star, Carly Pearce, Joins the Life DisRPted™ Campaign, Adding to Voices Advocating for Awareness of Recurrent Pericarditis
From Kiniksa Pharmaceuticals, Ltd.
Via GlobeNewswire
Earnings Scheduled For April 29, 2025
Via Benzinga
Earnings Scheduled For February 25, 2025
Via Benzinga
Exploring Kiniksa Pharmaceuticals's Earnings Expectations
Via Benzinga
Earnings Outlook For Kiniksa Pharmaceuticals
Via Benzinga
Earnings Outlook For Kiniksa Pharmaceuticals
Via Benzinga
These stocks are gapping in today's session
Via Chartmill
Honeywell Posts Better-Than-Expected Q1 Earnings, Joins Crown Holdings, Noble, Crane And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Examining the Future: Kiniksa Pharmaceuticals's Earnings Outlook
Via Benzinga
3 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now
Via The Motley Fool
Kiniksa Pharmaceuticals Stock Is Attractive From Valuation Perspective-JP Morgan Analyst
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
NHL Hall-of-Famer, Henrik Lundqvist, Teams Up with Kiniksa Pharmaceuticals to Launch Life DisRPted™ Campaign to Drive Awareness of Recurrent Pericarditis
From Kiniksa Pharmaceuticals, Ltd.
Via GlobeNewswire
Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
KNSA Stock Earnings: Kiniksa Pharmaceuticals Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Danaher Posts Upbeat Earnings, Joins Spotify, MSCI, Owens & Minor And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Sector Spotlight: Orphan Drug Developers With Significant Upside
Via AB Newswire
Topics ETFs
Exposures Product Safety
Sector Spotlight: Orphan Drug Developers With Significant Upside
Via TheNewswire.com
Topics ETFs
Exposures Product Safety
KNSA Stock Earnings: Kiniksa Pharmaceuticals Misses EPS, Beats Revenue for Q1 2024
Via InvestorPlace
The 3 Most Undervalued Biotech Stocks to Buy in December
Via InvestorPlace
7 Underappreciated Biotech Stocks to Pick Up on the Cheap
Via InvestorPlace
Topics Economy
Exposures Economy
Earnings Scheduled For April 23, 2024
Via Benzinga
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga

Frequently Asked Questions

Is Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares publicly traded?
Yes, Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares is publicly traded.
What exchange does Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares trade on?
Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares?
The ticker symbol for Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares is KNSA on the Nasdaq Stock Market
What is the current price of Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares?
The current price of Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares is 28.41
When was Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares last traded?
The last trade of Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares was at 06/16/25 04:00 PM ET
What is the market capitalization of Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares?
The market capitalization of Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares is 2.04B
How many shares of Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares are outstanding?
Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.